Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

(Mark One)

     
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934
     
  For the quarterly period ended March 28, 2004 or
     
[  ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

For the transition period from ________to _________

Commission file number 0-12933


LAM RESEARCH CORPORATION


(Exact name of registrant as specified in its charter)
     
Delaware
  94-2634797
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification Number)

4650 Cushing Parkway
Fremont, California 94538


(Address of principal executive offices including zip code)

(510) 572-0200


(Registrant’s telephone number, including area code)


     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ]

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES [X] NO [ ]

     As of April 27, 2004, there were 134,011,598 shares of Registrant’s Common Stock outstanding.



 


LAM RESEARCH CORPORATION
TABLE OF CONTENTS

         
    Page No.
       
       
    3  
    4  
    5  
    6  
    24  
    51  
    52  
       
    52  
    52  
    53  
    54  
    55  
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2

2


Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
                 
    March 28,   June 29,
    2004
  2003
    (unaudited)   (1)
ASSETS
               
Cash and cash equivalents
  $ 309,079     $ 167,343  
Short-term investments
    323,991       340,070  
Accounts receivable, net
    179,606       107,602  
Inventories
    110,746       112,016  
Prepaid expenses and other current assets
    17,819       12,679  
Deferred income taxes
    129,621       133,066  
 
   
 
     
 
 
Total current assets
    1,070,862       872,776  
Property and equipment, net
    37,477       48,771  
Restricted cash
    118,468       118,468  
Deferred income taxes
    87,032       87,032  
Other assets
    56,855       71,228  
 
   
 
     
 
 
Total assets
  $ 1,370,694     $ 1,198,275  
 
   
 
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Trade accounts payable
  $ 82,241     $ 35,518  
Accrued expenses and other current liabilities
    157,479       131,144  
Deferred profit
    56,599       45,309  
Current portion of long-term debt and other long-term liabilities
    3,750       5,011  
 
   
 
     
 
 
Total current liabilities
    300,069       216,982  
Long-term debt and other long-term liabilities less current portion
    322,944       332,209  
 
   
 
     
 
 
Total liabilities
    623,013       549,191  
Commitments and contingencies
               
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding
           
Common stock, at par value of $0.001 per share; authorized - 400,000 shares; issued and outstanding - 133,513 shares at March 28, 2004 and 127,435 shares at June 29, 2003
    134       127  
Additional paid-in capital
    615,412       560,273  
Deferred stock-based compensation
          (2,769 )
Treasury stock, at cost, 1,808 shares at March 28, 2004 and 2,712 shares at June 29, 2003
    (25,769 )     (38,670 )
Accumulated other comprehensive loss
    (12,402 )     (13,694 )
Retained earnings
    170,306       143,817  
 
   
 
     
 
 
Total stockholders’ equity
    747,681       649,084  
 
   
 
     
 
 
Total liabilities and stockholders’ equity
  $ 1,370,694     $ 1,198,275  
 
   
 
     
 
 

(1)   Derived from June 29, 2003 audited financial statements.

See Notes to Condensed Consolidated Financial Statements

3


Table of Contents

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
                                 
    Three Months Ended
  Nine Months Ended
    March 28,   March 30,   March 28,   March 30,
    2004
  2003
  2004
  2003
Total revenue
  $ 231,128     $ 187,059     $ 606,374     $ 569,148  
Cost of goods sold
    125,337       111,838       336,179       342,744  
Cost of goods sold - restructuring recoveries
    (322 )           (1,651 )     (301 )
 
   
 
     
 
     
 
     
 
 
Total cost of goods sold
    125,015       111,838       334,528       342,443  
 
   
 
     
 
     
 
     
 
 
Gross margin
    106,113       75,221       271,846       226,705  
 
   
 
     
 
     
 
     
 
 
Research and development
    42,914       38,981       120,518       120,102  
Selling, general and administrative
    37,218       33,245       105,352       98,319  
Restructuring charges, net
    1,317       4,043       8,327       6,096  
 
   
 
     
 
     
 
     
 
 
Total operating expenses
    81,449       76,269       234,197       224,517  
 
   
 
     
 
     
 
     
 
 
Operating income (loss)
    24,664       (1,048 )     37,649       2,188  
Loss on equity derivative contacts in Company stock
                      (16,407 )
Other income, net
    877       2,110       2,794       4,437  
 
   
 
     
 
     
 
     
 
 
Income (loss) before income taxes
    25,541       1,062       40,443       (9,782 )
Income tax expense
    6,385       265       10,110       1,656  
 
   
 
     
 
     
 
     
 
 
Net income (loss)
  $ 19,156     $ 797     $ 30,333     $ (11,438 )
 
   
 
     
 
     
 
     
 
 
Net income (loss) per share:
                               
Basic net income (loss) per share
  $ 0.14     $ 0.01     $ 0.23     $ (0.09 )
 
   
 
     
 
     
 
     
 
 
Diluted net income (loss) per share
  $ 0.13     $ 0.01     $ 0.22     $ (0.09 )
 
   
 
     
 
     
 
     
 
 
Number of shares used in per share calculations:
                               
Basic
    133,251       125,988       130,893       126,110  
 
   
 
     
 
     
 
     
 
 
Diluted
    147,365       129,550       138,527       126,110  
 
   
 
     
 
     
 
     
 
 

See Notes to Condensed Consolidated Financial Statements.

4


Table of Contents

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
                 
    Nine Months Ended
    March 28,   March 30,
    2004
  2003
CASH FLOWS FROM OPERATING ACTIVITIES:
               
Net income (loss)
  $ 30,333     $ (11,438 )
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
Loss on equity derivative contracts in Company stock
          16,407  
Amortization of premiums on securities
    2,958       4,641  
Depreciation and amortization
    21,971       30,504  
Deferred income taxes
    3,445       (5,426 )
Amortization of deferred stock-based compensation
    3,051       383  
Restructuring charges, net
    6,676       5,795  
Other, net
    722       354  
Change in working capital accounts
    5,589       (3,676 )
 
   
 
     
 
 
Net cash provided by operating activities
    74,745       37,544  
 
   
 
     
 
 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Capital expenditures
    (11,011 )     (9,528 )
Purchases of available-for-sale securities
    (418,475 )     (360,339 )
Sales of available-for-sale securities
    431,456       688,012  
Restricted cash released upon settlement of equity derivatives in Company stock
          (48,455 )
Other, net
    (200 )     1,333  
 
   
 
     
 
 
Net cash provided by investing activities
    1,770       271,023  
 
   
 
     
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Principal payments and redemptions on long-term debt and capital lease obligations
    (12 )     (361,259 )
Treasury stock purchases
          (39,122 )
Reissuances of treasury stock
    9,057       8,448  
Proceeds from issuance of common stock
    54,862       6,160  
 
   
 
     
 
 
Net cash provided by/(used for) financing activities
    63,907       (385,773 )
 
   
 
     
 
 
Effect of exchange rate changes on cash
    1,314       1,181  
Net increase (decrease) in cash and cash equivalents
    141,736       (76,025 )
Cash and cash equivalents at beginning of period
    167,343       172,431  
 
   
 
     
 
 
Cash and cash equivalents at end of period
  $ 309,079     $ 96,406  
 
   
 
     
 
 

See Notes to Condensed Consolidated Financial Statements.

5


Table of Contents

LAM RESEARCH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 28, 2004

(Unaudited)

NOTE 1 — BASIS OF PRESENTATION

     The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of Lam Research Corporation (the Company or Lam) for the fiscal year ended June 29, 2003, which are included in the Annual Report on Form 10-K, File Number 0-12933. The Company’s Form 10-K, Forms 10-Q and Forms 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is http://www.sec.gov. The Company also posts the Form 10-K, Forms 10-Q and Forms 8-K on the corporate website at http://www.lamrc.com.

     The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 27, 2004 and includes 52 weeks. The quarter ended March 28, 2004 and the quarter ended March 30, 2003 both included 13 weeks.

     Reclassifications: Certain amounts presented in the comparative financial statements for prior years have been reclassified to conform to the fiscal 2004 presentation.

NOTE 2 — RECENT ACCOUNTING PRONOUNCEMENTS

     Accounting for Revenue Arrangements with Multiple Deliverables: In November 2002, the Financial Accounting Standards Board’s (FASB) Emerging Issues Task Force (EITF) reached a consensus on EITF Issue No. 00-21, “Accounting for Revenue Arrangements with Multiple Deliverables” (EITF 00-21). EITF 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple deliverables (products, services, and/or rights to use assets). The provisions of EITF 00-21 are applicable for revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The adoption of EITF 00-21 did not have a material impact on the Company’s financial position or results of operations.

     Amendment of Statement 133, “Accounting for Derivative Instruments and Hedging Activities” (SFAS 133), on Derivative Instruments and Hedging Activities: In April 2003, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities”, (SFAS 149). SFAS 149 amends SFAS 133 for decisions made as part of the Derivatives Implementation Group (DIG) and changes financial reporting by requiring that contracts with comparable characteristics be accounted for similarly. Specifically, SFAS 149 (1) clarifies under what circumstances a contract with an initial net investment meets the characteristic of a derivative as discussed in SFAS 133, (2) clarifies when a derivative contains a financing component that requires reporting as cash flows from financing activities in the statement of cash flows and (3) amends the definition of an “underlying” to correspond to the language in FASB Interpretation (FIN) Number 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including

6


Table of Contents

Indirect Indebtedness of Others.” These changes will result in more consistent reporting of contracts that are derivatives in their entirety or that contain embedded derivatives that require separate accounting. SFAS 149 is effective for contracts entered into or modified after June 30, 2003, and for hedging relationships designated after June 30, 2003. However, the provisions of SFAS 149 that codify the previous decisions made by the DIG are already effective and should continue to be applied in accordance with their prior respective effective dates. The adoption of SFAS 149 did not have a material impact on the Company’s financial position or results of operations.

     Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity: In May 2003, the FASB issued Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity”, (SFAS 150). SFAS 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. SFAS 150 represents a significant change in practice in the accounting for a number of financial instruments including mandatorily redeemable equity instruments and certain equity derivatives that frequently are used in connection with share repurchase programs. SFAS 150 generally requires liability classification for two broad classes of financial instruments: (1) instruments that represent, or are indexed to, an obligation to buy back the issuer’s shares, regardless of whether the instrument is settled on a net-cash or gross physical basis, (2) obligations that can be settled in shares but meet one of the following conditions: (a) derive their value predominately from some other underlying, or (b) have a fixed value, or have a value to the counterparty that moves in the opposite direction as the issuer’s shares. Many of the instruments within the scope of SFAS 150 were previously classified by the issuer as equity or temporary equity. SFAS 150 is effective for financial instruments entered into or modified after May 31, 2003 and otherwise is effective the first quarter of fiscal 2004. The adoption of SFAS 150 did not have a material impact on the Company’s financial position or results of operations.

     Revenue Recognition: In December 2003, the Securities and Exchange Commission (SEC) issued Staff Accounting Bulletin (SAB) No. 104, “Revenue Recognition” (SAB 104). SAB 104 updates portions of the interpretive guidance included in Topic 13 of the codification of the Staff Accounting Bulletins in order to make this interpretive guidance consistent with current authoritative accounting and auditing guidance and SEC rules and regulations. The Company believes it is following the guidance of SAB 104, and the issuance of SAB 104 did not have a material impact on the Company’s financial position or results of operations.

NOTE 3 — STOCK-BASED COMPENSATION PLANS

     The Company has adopted stock option plans that provide for the grant to employees of various equity incentive awards, including options to purchase shares of Lam common stock. In addition, the plans permit the grant of nonstatutory stock options to paid consultants and employees, and provide for the automatic grant of nonstatutory stock options to outside directors. The Company also has an employee stock purchase plan (ESPP) that allows employees to purchase its common stock.

     The Company accounts for its stock option plans and stock purchase plan under the provisions of Accounting Principles Board (APB) Opinion No. 25, “Accounting for Stock Issued to Employees” (APB 25) and Financial Accounting Standards Board Interpretation (FIN) 44, “Accounting for Certain Transactions Involving Stock Compensation — an Interpretation of APB Opinion No. 25” (FIN 44). Pro forma information regarding net income (loss) and net income (loss) per share is required by SFAS No. 123, “Accounting for Stock-Based

7


Table of Contents

Compensation” (SFAS 123), as amended by SFAS No. 148, “Accounting for Stock-Based Compensation-Transition and Disclosure” (SFAS 148) as if the Company had accounted for its stock option and stock purchase plans under the fair value method of SFAS 123 and SFAS 148. The following table illustrates the effect on net income (loss) and net income (loss) per share if the Company had accounted for its stock option and stock purchase plans under the fair value method of accounting under SFAS 123 and SFAS 148:

                                 
    Three Months Ended
  Nine Months Ended
    March 28,   March 30,   March 28,   March 30,
    2004
  2003
  2004
  2003
            (in thousands, except per share data)        
Net income (loss) - as reported
  $ 19,156     $ 797     $ 30,333     $ (11,438 )
Add: compensation expense recorded under APB 25, net of tax
    212       329       2,288       458  
Deduct: SFAS 123 compensation expense, net of tax
    6,297       10,297       20,881       33,537  
 
   
 
     
 
     
 
     
 
 
Net income (loss) - pro forma
  $ 13,071     $ (9,171 )   $ 11,740     $ (44,517 )
 
Basic net income (loss) per share - as reported
  $ 0.14     $ 0.01     $ 0.23     $ (0.09 )
Basic net income (loss) per share - pro forma
    0.10       (0.07 )     0.09       (0.35 )
Diluted net income (loss) per share - as reported
    0.13       0.01       0.22       (0.09 )
Diluted net income (loss) per share - pro forma
  $ 0.09     $ (0.07 )   $ 0.08     $ (0.35 )

     For pro forma purposes, the estimated fair value of the Company’s stock-based awards is amortized over the options’ vesting period (for options) and the respective four, six, twelve, or fifteen-month purchase periods (for stock purchases under the employee stock purchase plan). The fair value of the Company’s stock options and stock purchase plans was estimated using a Black-Scholes option valuation model, which was developed for use in estimating the fair value of traded options which have no vesting restrictions and which are fully transferable. The model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each option. The fair value of the Company’s stock-based awards granted in the three and nine-month periods of fiscal 2004 and fiscal 2003 was estimated assuming no expected dividends and the following weighted-average assumptions:

                                                                 
    Options
  ESPP
    Three Months Ended   Nine Months Ended   Three Months Ended   Nine Months Ended
   
  
  
  
    March 28,   March 30,   March 28,   March 30,   March 28,   March 30,   March 28,   March 30,
    2004
  2003
  2004
  2003
  2004
  2003
  2004
  2003
Expected life(years)
    3.4       3.0       3.2       2.4       0.8       0.7       0.5       0.7  
Expected stock price volatility
    74 %     74 %     74 %     74 %     74 %     74 %     74 %     74 %
Risk-free interest rate
    2.1 %     2.2 %     2.0 %     1.5 %     2.0 %     2.2 %     2.0 %     1.5 %

NOTE 4 — INVENTORIES

     Inventories are stated at the lower of cost (first-in, first-out method) or market. Inventories consist of the following:

                 
    March 28,   June 29,
    2004
  2003
    (in thousands)
Raw materials
  $ 52,397     $ 67,259  
Work-in-process
    34,131       27,034  
Finished goods
    24,218       17,723  
 
   
 
     
 
 
 
  $ 110,746     $ 112,016  
 
   
 
     
 
 

8


Table of Contents

NOTE 5 — PROPERTY AND EQUIPMENT

     Property and equipment, net, consist of the following:

                 
    March 28,   June 29,
    2004
  2003
    (in thousands)
Manufacturing and office equipment
  $ 100,928     $ 114,609  
Leasehold improvements
    46,464       57,497  
Furniture and fixtures
    3,813       5,031  
Computer equipment and software
    60,007       67,624  
 
   
 
     
 
 
 
    211,212       244,761  
Less: accumulated depreciation and amortization
    (173,735 )     (195,990 )
 
   
 
     
 
 
 
  $ 37,477     $ 48,771  
 
   
 
     
 
 

NOTE 6 — LONG-TERM DEBT AND OTHER LONG-TERM LIABILITIES

     Long-term debt and other long-term liabilities consist of the following:

                 
    March 28,   June 29,
    2004
  2003
    (in thousands)
4% convertible subordinated notes, interest payable semi-annually, principal due June, 2006
  $ 312,807     $ 319,322  
Restructuring, long-term portion
    9,292       9,396  
Patent settlement obligation, long-term portion
          2,500  
Other
    845       991  
 
   
 
     
 
 
 
  $ 322,944     $ 332,209  
 
   
 
     
 
 

9


Table of Contents

     At March 28, 2004, obligations under debt financing consist of the Company’s 4% convertible subordinated notes (4% Notes). Details of the 4% Notes are:

     
Offering Date
  May 2001
 
   
Offering Amount
  $300.0 million
 
   
Maturity Date
  June 1, 2006
 
   
Offering Expenses
  $8.5 million at the time of offering, ratably amortized to other expense over the term of the 4% Notes. Remaining unamortized balance of $3.7 million and $5.0 million at March 28, 2004 and June 29, 2003, respectively.
 
   
Interest Rate Terms
  4% payable on June 1 and December 1 of each year, commencing December 1, 2001; payable in arrears.
 
   
Conversion Rights
  Convertible into Company Common Stock at any time prior to close of business on the maturity date, unless previously redeemed, at a conversion price of $44.93 per share subject to anti-dilution adjustments.
 
   
Redemption Terms
  Redeemable at the Company’s option, beginning June 5, 2004 with at least 20 days and no more than 60 days notice, at redemption prices starting at 101.0% and at diminishing prices thereafter, plus accrued interest.
 
   
Security
  4% Notes are unsecured and subordinated in right of payment in full to all existing and future senior indebtedness of the Company.

     The carrying value of the 4% Notes has been adjusted to reflect changes in fair value attributable to changes in the benchmark interest rate in connection with the Company’s fair value hedge accomplished through the interest rate swap agreement (the swap) discussed in Note 12. At March 28, 2004, the carrying value of the 4% Notes was $312.8 million as compared to $319.3 million at June 29, 2003. The corresponding gain of $6.5 million was recorded in other income (expense), offset by a recorded loss of $6.6 million on the carrying value of the swap during the nine months ended March 28, 2004.

     Under the terms of the agreement, the Company must provide a minimum of $6.0 million of collateral plus an amount equal to the unfavorable mark-to-market exposure (fair value) on the swap. Therefore, the amount of cash collateral the Company will have to post in the future will fluctuate from quarter to quarter commensurate with the unfavorable mark-to-market exposure on the swap instrument. Generally, the required collateral will rise as interest rates rise. The Company had $6.0 million of collateral (reflected as restricted cash) recorded on the consolidated balance sheet related to this agreement as of March 28, 2004 and June 29, 2003.

     In April, 2004, the Company settled its interest rate swap agreement and announced plans to repay in full its 4% Notes in June 2004, two years prior to their maturity. Please see Note 16 for additional information.

     The Company’s 5% Convertible Subordinated Notes matured on September 2, 2002 and were repaid in full. This resulted in a cash outlay of approximately $309.8 million in the September 2002 quarter.

10


Table of Contents

NOTE 7 — DEFERRED STOCK-BASED COMPENSATION

     During the quarter ended December 29, 2002, the Company recorded $3.4 million of deferred stock-based compensation in stockholders’ equity, which was offset by a corresponding entry to additional paid-in capital in stockholders’ equity, in connection with the modification of terms of a fixed stock option award previously issued to the Company’s Chairman and Chief Executive Officer. The modification extended the contractual life of the stock option for a period of three years and modified the vesting requirements. However, no changes were made to either the number of shares of the Company’s stock subject to the option, or the option’s exercise price. Accordingly, the modification resulted in the remeasurement of compensation expense based on the option’s intrinsic value on the date of modification in accordance with the provisions of APB 25 and FIN 44. The deferred stock-based compensation balance of $3.4 million was being amortized ratably over the vesting period of the modified options, or 16 quarters. Under the terms of this modification, if the Nasdaq National Market closing price of the Company’s common stock reached or exceeded $20.00 per share, all unvested shares would immediately vest and become exercisable. In the event of such accelerated vesting, all remaining deferred compensation would immediately be recognized as compensation expense.

     During the quarter ended September 28, 2003, the Company added a second condition to the accelerated vesting provision contained in this stock option award. The second condition required the Company’s fiscal quarter net income, based on U.S. generally accepted accounting principles, to exceed $2.5 million after deducting any incremental amortization expense that resulted from acceleration of these same options. The two conditions needed not to be met simultaneously nor in a specific order. Both conditions were met during the quarter ended September 28, 2003 and, as a result, all options under this arrangement were immediately vested in full. Accordingly, the Company recognized the remaining deferred stock-based compensation balance of $2.8 million as compensation expense within selling, general and administrative expenses in the Company’s condensed consolidated statement of operations for the three months ended September 28, 2003.

NOTE 8 — OTHER INCOME (EXPENSE), NET

     The significant components of other income (expense), net, are as follow:

                                 
    Three Months Ended
  Nine Months Ended
    March 28,   March 30,   March 28,   March 30,
    2004
  2003
  2004
  2003
    (in thousands)   (in thousands)
Interest income
  $ 2,437     $ 3,296     $ 7,387     $ 13,126  
Loss on equity derivative contracts
                      (16,407 )
Interest expense
    (627 )     (718 )     (1,996 )     (5,322 )
Foreign exchange gain (loss)
    258       378       (49 )     (503 )
Debt issue cost amortization
    (425 )     (785 )     (1,275 )     (2,111 )
Interest rate swap hedge ineffectiveness
    (214 )     (7 )     (92 )     (179 )
Equity method investment losses
    (254 )     (109 )     (415 )     (606 )
Other, net
    (298 )     55       (766 )     32  
 
   
 
     
 
     
 
     
 
 
 
  $ 877     $ 2,110     $ 2,794     $ (11,970 )
 
   
 
     
 
     
 
     
 
 

11


Table of Contents

NOTE 9 — NET INCOME (LOSS) PER SHARE

     Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed as though all potential common shares that are dilutive were outstanding during the period. The following table provides a reconciliation of the numerators and denominators of the basic and diluted computations for net income (loss) per share.

<
                                 
    Three Months Ended
  Nine Months Ended
    March 28,   March 30,   March 28,   March 30,
    2004
  2003
  2004
  2003
    (in thousands, except per share data)
Numerator:
                               
Numerator for basic net income (loss) per share
  $ 19,156     $ 797     $ 30,333     $ (11,438 )
 
   
 
     
 
     
 
     
 
 
Add:
                               
Interest expense on convertible subordinated 4% notes, net of income taxes
    434                    
 
   
 
     
 
     
 
     
 
 
Numerator for diluted net income (loss) per share
  $ 19,590     $ 797     $ 30,333     $ (11,438 )
 
   
 
     
 
     
 
     
 
 
Denominator:
                               
Basic average shares outstanding
    133,251       125,988       130,893       126,110